Heart Disease Trial, Recruiting NCT06920927 Sponsor: University of Calgary Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06920927
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have been diagnosed with chronic kidney disease
  • People who have coronary artery disease, either a type called non-ST elevation acute coronary syndrome (a certain kind of heart attack or chest pain episode) or ongoing symptoms of stable heart disease (confirm with trial site)
  • People who can communicate in English or French, or who have a support person with them who speaks English or French
  • People who are able to take part in discussions about their care and treatment decisions, either on their own or with the help of a trusted person who can make decisions on their behalf, as determined by their treating doctor

Who may not be able to join:

  • People whose kidneys have failed to the point where they are already receiving dialysis, or whose kidney function test result is below a very low threshold (eGFR less than 10 mL/min/1.73m²)
  • People who have had a specific type of serious heart attack called an ST-elevation myocardial infarction
  • People who are not expected to survive until they leave the hospital

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Matthew T James, MD, University of Calgary

Phone: 1 (403) 220 2465

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Calgary
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
30 April 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Decisional Conflict Scale (O'Connor -8 question); Patient Nine-item Shared Decision-Making Questionnaire (SDM-Q-9); Knowledge of Treatment Risks; Accuracy of Risk Perception; Value-Choice Congruence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov